FKBP4 and neoplasm: To test the involvement of FKBP4 in tumor growth in vivo, we established a MDA-MB-231 cell line-derived xenograft (CDX) tumor model in athymic mice, by injecting cells stably transfected with FKBP4-targeting shRNA, or with non-targeting shRNA.